| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.00093 | 1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.00046 | 1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.00065 | 1 |